Title: Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
Authors: MURATOV SERGEICANELO-AYBAR CARLOSTARRIDE JEAN-ERICCOELLO PABLO ALONSODIMITROVA NADYABORISCH BETTINACASTELLS XAVIERDUFFY STEPHEN WFITZPATRICK PATRICIAFOLLMANN MARKUSGIORDANO LIVIAHOFVIND SOLVEIGLEBEAU ANNETTEQUINN CECILYTORRESIN ALBERTOVIALLI CLAUDIASIESLING SABINEPONTI ANTONIOROSSI GIORGI PAOLOSCHUNEMANN HOLGERNYSTROM LENNARTHBROEDERS MIREILLE
Citation: BMC CANCER vol. 20 no. 795 p. 1-10
Publisher: BMC
Publication Year: 2020
JRC N°: JRC117491
ISSN: 1471-2407 (online)
URI: https://publications.jrc.ec.europa.eu/repository/handle/JRC117491
DOI: 10.1186/s12885-020-07289-z
Type: Articles in periodicals and books
Abstract: ABSTRACT Objective In the scope of the European Commission Initiative on Breast Cancer (ECIBC), the Monitoring and Evaluation (M&E) group was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated with breast cancer (BC) mortality. This paper documents the methodology used for the indicator selection. Methods The indicators were identified through a multi-stage process. First, a scoping review was conducted to identify existing performance indicators. Second, building on existing frameworks for making well-informed health care choices, a specific conceptual framework was developed to guide the indicator selection. Third, two group exercises including a rating and ranking survey were conducted for indicator selection using pre-determined criteria, such as: relevance, measurability, accurateness, ethics and understandability. The selected indicators were mapped onto a BC screening pathway developed by the M&E subgroup to illustrate the steps of BC screening common to all EU countries. Results A total of 96 indicators were identified from an initial list of 1,325 indicators. After removing redundant and irrelevant indicators and adding those missing, 39 candidate indicators underwent the rating and ranking exercise. Based on the results, the M&E subgroup selected 13 indicators: screening coverage, participation rate, recall rate, breast cancer detection rate, invasive breast cancer detection rate, cancers >20mm, cancers ≤10 mm, lymph node status, interval cancer rate, episode sensitivity, time interval between screening and first treatment, benign open surgical biopsy rate, and mastectomy rate Conclusion This systematic approach led to the identification of 13 BCSP candidate performance indicators to be further evaluated for their association with BC mortality.
JRC Directorate:Health, Consumers and Reference Materials

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.